|
|
Article: Dynavax Introduces TOLAMBA(TM) and HEPLISAV(TM) Brand Names for Ragweed Allergy and Hepatitis B Vaccine Products.
- Article from:
- PR Newswire
- Article date:
- September 27, 2005
CopyrightCOPYRIGHT 2005 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BERKELEY, Calif., Sept. 27 /PRNewswire-FirstCall/ -- Dynavax Technologies Corporation announced the selection of TOLAMBA(TM) and HEPLISAV(TM) as brand names for its ragweed allergy immunotherapy (formerly, AIC) and hepatitis B prophylaxis products, respectively. Both TOLAMBA and HEPLISAV are in Phase 3 trials. TOLAMBA and HEPLISAV are based on Dynavax's proprietary immunostimulatory sequence (ISS) technology that reprograms the immune system through specific targeting of Toll-Like Receptor 9 (TLR-9) to stimulate an innate immune response. The company believes that TOLAMBA and HEPLISAV are the most advanced TLR-9 agonist-based products in clinical development today.
...
Related newspaper, magazine, and journal articles:
|
|
Article: Dynavax and Merck & Co., Inc. Report Clinical Hold of ...
Business Wire;
March 17, 2008 ;
700+ words
... ... discuss the current status of its HEPLISAV program. The live webcast ... product candidates include: HEPLISAV, a hepatitis B vaccine in ... Merck & Co. Inc.; TOLAMBA(TM), a ragweed allergy ... related to the clinical status of HEPLISAV, the timing of discussions ...
|
|